Literature DB >> 2942070

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.

P N Casale, R B Devereux, M Milner, G Zullo, G A Harshfield, T G Pickering, J H Laragh.   

Abstract

To assess whether echocardiographic and electrocardiographic detection of left ventricular hypertrophy could predict cardiovascular morbid events in patients with uncomplicated essential hypertension, we followed 140 men for a mean of 4.8 years. Initial echocardiographic measurements of left ventricular mass were normal (less than 125 g/m2 body surface area) in 111 patients and revealed hypertrophy in 29 patients. Morbid events occurred in more patients with hypertrophy on echocardiography (7 of 29, 4.6/100 patient-years) than with normal ventricular mass (7 of 111, 1.4/100 patient-years; p less than 0.01). Electrocardiography showed hypertrophy in too few patients to be of predictive value. Multiple logistic regression analysis showed that left ventricular mass index had the highest independent relative risk for future events and that systolic and diastolic pressures and age had slightly lower relative risks. In men with mild uncomplicated hypertension, left ventricular hypertrophy detected by echocardiography identifies patients at high risk for cardiovascular morbid events and is a significant risk factor for future morbid events independent of age, blood pressure, or resting ventricular function.

Entities:  

Mesh:

Year:  1986        PMID: 2942070     DOI: 10.7326/0003-4819-105-2-173

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  125 in total

1.  Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.

Authors:  E Foster; J F Plehn; S A Bernard; N J Battinelli; M Huntington-Coats; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

2.  Relation between socioeconomic status, race-ethnicity, and left ventricular mass: the Northern Manhattan study.

Authors:  Carlos J Rodriguez; Robert R Sciacca; Ana V Diez-Roux; Bernadette Boden-Albala; Ralph L Sacco; Shunichi Homma; Marco R DiTullio
Journal:  Hypertension       Date:  2004-02-23       Impact factor: 10.190

3.  Relationship between left ventricular mass and coronary artery disease in young adults: a single-center study using cardiac computed tomography.

Authors:  Jae Yong Cho; Joo Sung Sun; Young Keun Sur; Jin Sun Park; Doo Kyoung Kang
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-01       Impact factor: 2.357

Review 4.  Epidemiologic factors in the management of hypertension.

Authors:  E Saunders
Journal:  J Natl Med Assoc       Date:  1989-04       Impact factor: 1.798

Review 5.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

6.  Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study.

Authors:  Suh-Hang Hank Juo; Marco R Di Tullio; Hsiu-Fen Lin; Tanja Rundek; Bernadette Boden-Albala; Shunichi Homma; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

Review 7.  Antihypertensive drugs and the heart.

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

8.  Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.

Authors:  Gabriel Paris; Sudheer R Gorla; Aura J Arenas-Morales; Wacharee Seeherunvong; Sethuraman Swaminathan
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

9.  Effects of fixed combination of lisinopril plus hydrochlorothiazide on regression of left ventricular hypertrophy in patients with essential hypertension: an opened, multi-centre, prospective clinical trial.

Authors:  Vjekoslav Gerc; Begler Begović; Midhat Vehabović; Leonid Georgievich Voronkov; Eleonora Vataman; Ljiljana Musić; Marko Buksa; Zumreta Kusljugić; Fahir Baraković; Vera Iosifovna Tchelujko; Alexander Ivanovich Dyaduk; Svetlana Alekseevna Andrievskaja; Andrey Eduardovich Bagrij; Sergey Nikolaevich Polivoda; Aleksandar Lazarević; Bozidarka Knezević; Faik Hima
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

Review 10.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.